The Involvement of 5-Hydroxytryptamine Receptors in the Action of Anti-Migraine Drugs

Fozard JR . The animal pharmacology of drugs used in the treatment of migraine. J Pharm Pharmac 1975; 27: 297–321.

Bradley PB Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25: 563–576.

Peatfield RC Drug Treatment of Migraine. Handbook of Clinical Neurology 1986; 4: 173–216.

Loisy C Effects on migraine headache of MDL72222 an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study. Cephalalgia 1985; 5: 79–82.

Angus JA Van Nueten JM . Pathophysiology of 5-hydroxytryptamine: An overview. In: Mylecharane EJ eds Serotonin: Actions, receptors, pathophysiology. Basingstoke, England: Macmillan Press Ltd 1989: 274–279.

Parsons AA 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989; 96: 434–449.

Humphrey PPA Sumatriptan succinate. Drugs of the Future 1989; 14(1): 35–39.

Humphrey PPA The pharmacology of the novel 5-HT1-like receptor agonist, GR43175. Cephalalgia 1989; 9(9): 23–33.

Perrin VL Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia 1989; 9(9): 63–72.

Moskowitz MA . Sensory connections to cephalic blood vessels and their possible importance to vascular headaches. In: Rose FC ed Advances in Headache Research. London: John Libby & Co 1987: 81–86.

Humphrey PPA Further studies on the mechanism of the anti-migraine action of sumatriptan. Cephalalgia, this volume.